Answer first: beyond breathing-pause counts and oxygen levels, researchers measure what patients themselves report — daytime sleepiness, sleep-related quality of life, snoring, satisfaction with treatment, and preference between therapies. That research generally shows improvement in these measures with oral appliance therapy, alongside a consistent pattern: many patients find oral appliances easier to use consistently than CPAP.
The numbers behind that summary are worth knowing accurately. A 2021 systematic review of quality-of-life research identified 25 studies (17 contributing to quantitative analysis) and found that sleep-related quality of life, measured by the Functional Outcomes of Sleep Questionnaire (FOSQ), improved significantly with oral appliance treatment — an average difference of about 1.8 points from baseline. A 2025 prespecified analysis of the CRESCENT trial reported that both oral appliances and CPAP improved sleepiness and sleep-related quality of life, with CPAP showing somewhat greater improvement on some measures at some time points and no between-group difference on others.
Patient-reported improvement matters — feeling less sleepy and sleeping better are among the reasons treatment exists. But subjective reports are not objective verification: sleep-disordered breathing can persist even as symptoms improve. Four easy-to-confuse things run through this page: what a patient reports, what a bed partner reports, how much the appliance is worn, and whether treatment efficacy has been confirmed on sleep testing.
Patient-reported outcomes (PROs) are structured research measures of what patients experience: sleepiness, quality of life, snoring, satisfaction, and preference.
A 2021 systematic review found sleep-related quality of life (FOSQ) improved significantly with oral appliance therapy across 17 studies in its quantitative analysis.
In a CRESCENT trial analysis, both oral appliances and CPAP improved sleepiness and sleep-related quality of life; some measures favored CPAP at some time points, others showed no between-group difference.
Subjective improvement is a real, meaningful treatment goal — it is not proof that breathing events have resolved.
Patient reports, bed-partner reports, adherence, and confirmed efficacy are four different things; research and good care keep them separate.
Guideline-recommended follow-up sleep testing remains the way efficacy is confirmed. See follow-up sleep testing.
What Patient-Reported Outcomes Are
Patient-reported outcomes (PROs) are measurements built from what patients themselves say they experience, usually collected with validated questionnaires rather than casual conversation. In oral appliance research the most common are sleepiness scales (such as the Epworth Sleepiness Scale), sleep-related quality-of-life instruments (such as the Functional Outcomes of Sleep Questionnaire, FOSQ, and the Sleep Apnea Quality of Life Index, SAQLI), snoring reports — often from the bed partner, who hears more of it — and measures of satisfaction and preference between treatments.
Researchers use PROs because the point of treatment is not a prettier sleep-study report; it is a patient who feels and functions better. A therapy that normalizes numbers without improving lived experience, or vice versa, is not a complete success. Good research reports both dimensions, which is why PROs sit alongside objective endpoints rather than replacing them.
What the Research Reports
Quality of life
A 2021 systematic review (registered in advance on PROSPERO) searched multiple literature databases for studies of quality of life in patients with OSA treated with mandibular advancement appliances. It identified 25 studies, with 17 contributing to the quantitative synthesis. Across those studies, quality of life measured by the FOSQ improved significantly after treatment — an average difference of about 1.8 points from baseline. That is a group-level finding: it tells you the average studied patient improved, not that every patient did.
Head-to-head with CPAP: the CRESCENT analysis
A prespecified analysis of the CRESCENT trial, published in the journal Sleep in 2025, compared patient-reported outcomes of a mandibular advancement device versus CPAP in 220 adults over 40 with OSA, hypertension, and increased cardiovascular risk. Both groups improved significantly in sleepiness (Epworth), FOSQ, and SAQLI at six and twelve months. CPAP showed somewhat greater improvement on some measures at some time points — sleepiness at six months and FOSQ at twelve months — while SAQLI showed no significant between-group difference. Reported nightly use was similar and substantial in both groups (about 5.5 hours with the oral appliance and about 4.9 hours with CPAP at six months).
The honest reading: both therapies made patients feel measurably better; neither dominated the other on every measure; and group averages again do not predict individual experience. The trial’s blood-pressure findings are covered separately in oral appliances and cardiovascular evidence.
Snoring, satisfaction, and preference
Snoring outcomes in oral appliance research rely heavily on bed-partner reports, since the sleeper rarely hears their own snoring. Studies and reviews generally report substantial reductions in reported snoring, and satisfaction and preference studies consistently find that many patients find oral appliances more comfortable and convenient than CPAP — a pattern related to adherence, covered in our adherence guide. Preference for a device, however, is a statement about comfort and convenience, not about how well sleep apnea itself is being controlled.
Why Subjective Improvement Matters — and Where Its Limits Are
Feeling less sleepy, sleeping through the night, waking rested, and letting a partner sleep undisturbed are not consolation prizes — they are core treatment goals, and their improvement is a genuine, researched benefit of therapy. Patient-reported measures deserve their place alongside sleep-study numbers.
The limit is this: symptoms are an imperfect proxy for physiology. Sleep-disordered breathing can persist after snoring quiets and sleepiness lifts, which is why improvement in how you feel cannot, by itself, confirm that sleep apnea is adequately controlled. That confirmation comes from objective follow-up testing when ordered by your physician — a guideline recommendation explained in how to know if your appliance is working and follow-up sleep testing. Subjective and objective evidence are complements, not substitutes.
Four Things That Are Easy to Confuse
| Criteria | What It Is | What It Tells You | What It Does Not Tell You |
|---|---|---|---|
| Patient report | What the patient experiences: sleepiness, rest, morning symptoms | Whether breathing events or oxygen have actually normalized | |
| Bed-partner report | Snoring and observed breathing changes from outside the bed | The patient’s own experience or objective sleep-study results | |
| Adherence | How many hours per night the appliance is actually worn | Whether the appliance is effectively controlling the condition while worn | |
| Confirmed efficacy | Objective verification from physician-ordered follow-up sleep testing | Symptoms, comfort, or satisfaction — those require asking the patient |
Scope, Limitations, and Medical Disclaimer
This page summarizes published research on patient-reported outcomes for education. It does not predict how you will feel on therapy, does not diagnose any condition, and does not recommend or evaluate any individual’s treatment. Reported group averages — including every figure on this page — describe studied populations, not you.
If your symptoms improve on therapy, tell your providers — and still complete the follow-up testing they order. If symptoms persist despite treatment, contact your treating provider; seek urgent care for severe or alarming symptoms such as chest pain, severe shortness of breath, or fainting.
Frequently Asked Questions
If I feel better, do I still need a follow-up sleep study?+
Do patients prefer oral appliances over CPAP?+
What is the FOSQ?+
References
Systematic review of quality-of-life outcomes with mandibular advancement appliances for OSA — 25 studies identified, 17 in the quantitative synthesis, FOSQ improvement of approximately 1.8 points (Sleep and Breathing, 2021; PROSPERO-registered).
Patient-reported quality-of-life outcomes with mandibular advancement versus CPAP: a prespecified analysis of the CRESCENT trial (Sleep, 2025).
American Academy of Sleep Medicine and American Academy of Dental Sleep Medicine — joint clinical practice guideline, including the follow-up sleep-testing recommendation (Journal of Clinical Sleep Medicine, 2015).
For how this site selects and applies its sources, see Evidence & Sources and the Medical Content Policy.
Feel Better — and Verify
Symptom improvement and objective verification are the two halves of a well-managed treatment. Learn how both fit together.
IS YOUR APPLIANCE WORKING?